ISRCTN87061665已完成不适用
A pilot study to determine the impact of therapeutic Human Immunodeficiency Virus (HIV) vaccination followed by a scheduled interruption of antiretroviral therapy on HIV-specific immune function by a scheduled virologic rebound in patients with prolonged viral suppression
Ottawa Hospital Research Institute (Canada)0 个研究点目标入组 60 人开始时间: 2005年11月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. HIV positive CD4 greater than 500
- •2. Age 18 years and older, either sex
- •3. CD4 nadir greater than 250
- •4. Viral load less than 50 for greater than 2 years
- •5. Receiving a Protease Inhibitor (PI) or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
排除标准
- •1. Patients with previous Acquired Immunodeficiency Syndrome (AIDS) defining opportunistic infections, previous cancer chemotherapy or other system immunosuppressive therapy
- •2. Patients with concurrent infections with hepatitis C or hepatitis B or any other acute illness
研究者
相似试验
招募中
2 期
A pilot study to evaluate the therapeutic efficacy of kurosani ommumsathu (internal) in the management ofthookaminmai (insomnia)CTRI/2014/04/004520ATIONAL INSTITUTE OF SIDDHA10
已完成
2 期
Siddha treatment for Joint paiCTRI/2010/091/006125ational Institute of Siddha Chennai Tamil Nadu India40
尚未招募
2 期
A Study to find the Effectiveness of Siddha treatment for Vathakarsanam (Diabetic Peripheral Neuropathy)CTRI/2024/06/069492I
尚未招募
2 期
A Pilot Clinical study of Siddha Medicine in the treatment of Pen Maladu (Female Infertility)CTRI/2017/03/008067ational Institute of Siddha10
已完成
2 期
Study of a combination of fenugreek/phaseolamin as a new weight loss agentDiet and Nutrition - ObesityObesityACTRN12607000130460Southern European Health Marketing Ltd39